Correction to: Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA

Correction to: Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from ¹⁸F-FDG-PET/CT and circulating tumor DNA

Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1613. doi: 10.1007/s00259-019-04672-2.

¹ Department of Nuclear Medicine, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany. christian.schmidkonz@uk-erlangen.de.
² Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
³ Department of Nuclear Medicine, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
⁴ Pediatrics III, West German Cancer Centre, University Hospital of Essen, Essen, Germany.
⁵ Institute of Pathology, University Hospital, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
⁶ Division of Translational Pathology, Gerhard-Domagk Institute of Pathology, University Hospital of Münster, Münster, Germany.
⁷ Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany.
⁸ Institute of Radiology Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.

The author names and family names of the originally published article was inversed. Correct presentation is presented here.